Paukner, S.; Mariano, D.; Das, A.F.; Moran, G.J.; Sandrock, C.; Waites, K.B.; File, T.M., Jr.
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials. Antibiotics 2021, 10, 1489.
https://doi.org/10.3390/antibiotics10121489
AMA Style
Paukner S, Mariano D, Das AF, Moran GJ, Sandrock C, Waites KB, File TM Jr.
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials. Antibiotics. 2021; 10(12):1489.
https://doi.org/10.3390/antibiotics10121489
Chicago/Turabian Style
Paukner, Susanne, David Mariano, Anita F. Das, Gregory J. Moran, Christian Sandrock, Ken B. Waites, and Thomas M. File, Jr.
2021. "Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials" Antibiotics 10, no. 12: 1489.
https://doi.org/10.3390/antibiotics10121489
APA Style
Paukner, S., Mariano, D., Das, A. F., Moran, G. J., Sandrock, C., Waites, K. B., & File, T. M., Jr.
(2021). Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials. Antibiotics, 10(12), 1489.
https://doi.org/10.3390/antibiotics10121489